Provided by Tiger Trade Technology Pte. Ltd.

Co-Diagnostics, Inc.

1.24
+0.03002.48%
Post-market: 1.240.00000.00%16:10 EDT
Volume:68.78K
Turnover:84.55K
Market Cap:8.66M
PE:-0.05
High:1.27
Open:1.21
Low:1.20
Close:1.21
52wk High:46.50
52wk Low:0.9396
Shares:6.98M
Float Shares:6.86M
Volume Ratio:0.40
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-23.8424
EPS(LYR):-37.2229
ROE:-174.77%
ROA:-59.63%
PB:0.68
PE(LYR):-0.03

Loading ...

Co-Diagnostics advances pan-Ebola, multiplex PCR test development with CoSara JV

Reuters
·
Jun 02

Co-Diagnostics files to sell 4.94M shares of common stock for holders

TIPRANKS
·
May 29

Co-Diagnostics trading resumes

TIPRANKS
·
May 27

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:59 AM

Reuters
·
May 27

Top Midday Gainers

MT Newswires Live
·
May 27

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

TIPRANKS
·
May 26

Co-Diagnostics, CoSara plan Bundibugyo Ebola PCR assay program for global deployment

Reuters
·
May 26

Co-Diagnostics Advances Ebola Pcr Assay Development Strategy With Joint Venture Cosara

THOMSON REUTERS
·
May 26

Top Premarket Gainers

MT Newswires Live
·
May 21

Co-Diagnostics prices USD 3 million private placement at market under Nasdaq rules

Reuters
·
May 20

Co-Diagnostics Announces $3.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
May 20

BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy

Reuters
·
May 19

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

TIPRANKS
·
May 19

Co-Diagnostics plans rapid rollout of Bundibugyo Ebola PCR test if needed

Reuters
·
May 19

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

THOMSON REUTERS
·
May 19

Co-Diagnostics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Co-Diagnostics Q1 FY26 net loss widens to $9.1 million; revenue holds at $0.1 million

Reuters
·
May 15

Co-Diagnostics Q1 revenue rises but net loss widens

Reuters
·
May 15

Co-Diagnostics Q1 EPS $(4.06) Misses $(3.90) Estimate, Sales $145.954K Miss $163.500K Estimate

Benzinga Earnings
·
May 15

Co-Diagnostics Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 15